AlphaYouJH
Insider buying
Jason Haas bought $20K of Odyssey Therapeutics, Inc. (ODTX) stock
Jason Haas, Chief Financial Officer of Odyssey Therapeutics, Inc. (ODTX), bought 1,000 shares of ODTX stock worth $20K, per an SEC Form 4 filed May 12, 2026.
It was an open-market purchase.
The trade happened on May 8, 2026, 4 days before it was made public.
ODTX has moved +40.4% since the trade date, from $16.42 to $23.06 (Sep 21, 2026 close).
- Traded
- May 8, 2026
- Disclosed
- May 12, 2026
- Filing delay
- 4 days
- Price since
- +40.4%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More ODTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.